Discovery of Precision Oncology Drugs
NTRC provides in vitro drug discovery services focused on Precision Medicine. We help you to find the informed route to the clinic. Information can be found at www.oncolines.com
Comparative cancer cell panel profiling of kinase inhibitors
The poster presents the biochemical and cellular profiling of newly-approved kinase inhibitors and other inhibitors which act on the same target. The compounds are compared side by side based on their selectivity and potency on primary and secondary targets.